Stewart Appelrouth - 31 Dec 2024 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
Director
Signature
/s/ Stewart Appelrouth
Issuer symbol
AIMI
Transactions as of
31 Dec 2024
Net transactions value
+$1,736
Form type
4
Filing time
03 Jan 2025, 16:35:19 UTC
Previous filing
17 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Award $1,736 +8,768 +2.3% $0.1980 388,729 31 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Stewart Appelrouth is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.